View in EDS HTML Full Text PDF Full Text

Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers.

Saved in:
Bibliographic Details
Title: Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers.
Authors: Agnes JT; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Marcus SA; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Al-Ghraibeh SS; Department of Internal Medicine, Faculty of Medicine, Yarmouk University, Irbid, Jordan., Al-Sweedan SA; Department of Pediatric Hematology/Oncology/BMT, King Abdullah University Hospital, Faculty of Medicine, Jordan University of Science & Technology, Ar Ramtha, Irbid, Jordan., Kosgei J; Kenya Medical Research Institute/Walter Reed Project Clinical Research Center, Kericho Clinical Research Site, Kericho, Kenya., Ogutu B; Kenya Medical Research Institute (KEMRI), Nairobi, Kenya., Yang S; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Walker KA; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Orizu B; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Broderick KE; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Boyer J; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Ramos S; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Morrow MP; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Kraynyak K; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Sylvester AJ; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Gillespie E; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Liebowitz D; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Humeau LM; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.
Source: Frontiers in immunology [Front Immunol] 2025 Nov 14; Vol. 16, pp. 1662923. Date of Electronic Publication: 2025 Nov 14 (Print Publication: 2025).
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41322416
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Agnes+JT%22">Agnes JT</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Marcus+SA%22">Marcus SA</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Al-Ghraibeh+SS%22">Al-Ghraibeh SS</searchLink>; Department of Internal Medicine, Faculty of Medicine, Yarmouk University, Irbid, Jordan.<br /><searchLink fieldCode="AU" term="%22Al-Sweedan+SA%22">Al-Sweedan SA</searchLink>; Department of Pediatric Hematology/Oncology/BMT, King Abdullah University Hospital, Faculty of Medicine, Jordan University of Science & Technology, Ar Ramtha, Irbid, Jordan.<br /><searchLink fieldCode="AU" term="%22Kosgei+J%22">Kosgei J</searchLink>; Kenya Medical Research Institute/Walter Reed Project Clinical Research Center, Kericho Clinical Research Site, Kericho, Kenya.<br /><searchLink fieldCode="AU" term="%22Ogutu+B%22">Ogutu B</searchLink>; Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Yang+S%22">Yang S</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Walker+KA%22">Walker KA</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Orizu+B%22">Orizu B</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Broderick+KE%22">Broderick KE</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Boyer+J%22">Boyer J</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Ramos+S%22">Ramos S</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Morrow+MP%22">Morrow MP</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Kraynyak+K%22">Kraynyak K</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Sylvester+AJ%22">Sylvester AJ</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Gillespie+E%22">Gillespie E</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Liebowitz+D%22">Liebowitz D</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Humeau+LM%22">Humeau LM</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Nov 14; Vol. 16, pp. 1662923. <i>Date of Electronic Publication: </i>2025 Nov 14 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41322416
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1662923
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1662923
    Titles:
      – TitleFull: Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Agnes JT
      – PersonEntity:
          Name:
            NameFull: Marcus SA
      – PersonEntity:
          Name:
            NameFull: Al-Ghraibeh SS
      – PersonEntity:
          Name:
            NameFull: Al-Sweedan SA
      – PersonEntity:
          Name:
            NameFull: Kosgei J
      – PersonEntity:
          Name:
            NameFull: Ogutu B
      – PersonEntity:
          Name:
            NameFull: Yang S
      – PersonEntity:
          Name:
            NameFull: Walker KA
      – PersonEntity:
          Name:
            NameFull: Orizu B
      – PersonEntity:
          Name:
            NameFull: Broderick KE
      – PersonEntity:
          Name:
            NameFull: Boyer J
      – PersonEntity:
          Name:
            NameFull: Ramos S
      – PersonEntity:
          Name:
            NameFull: Morrow MP
      – PersonEntity:
          Name:
            NameFull: Kraynyak K
      – PersonEntity:
          Name:
            NameFull: Sylvester AJ
      – PersonEntity:
          Name:
            NameFull: Gillespie E
      – PersonEntity:
          Name:
            NameFull: Liebowitz D
      – PersonEntity:
          Name:
            NameFull: Humeau LM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 11
              Text: 2025 Nov 14
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1